相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and variation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Mika Hilvo et al.
EUROPEAN HEART JOURNAL (2020)
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
Jorge Simon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease
Annelise M. Poss et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Mika Hilvo et al.
EUROPEAN HEART JOURNAL (2020)
Hepatic stellate cell activation: A source for bioactive lipids
Igor O. Shmarakov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)
An ANGPTL4-ceramide-protein kinase C axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice
Tzu-Chieh Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Ceramides bind VDAC2 to trigger mitochondrial apoptosis
Shashank Dadsena et al.
NATURE COMMUNICATIONS (2019)
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Bhagirath Chaurasia et al.
SCIENCE (2019)
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Claudio Tana et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion - A step towards precision medicine
Bernard Thorens et al.
MOLECULAR METABOLISM (2019)
Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
Meng Jiang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
Rui-Xu Yang et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism
Sophie A. Montandon et al.
SCIENTIFIC REPORTS (2019)
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
Suryaprakash Raichur et al.
MOLECULAR METABOLISM (2019)
Non-alcoholic fatty liver disease: Insights from sphingolipidomics
David J. Montefusco et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
Rozenn N. Lemaitre et al.
DIABETES (2018)
Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
Panu K. Luukkonen et al.
DIABETES CARE (2018)
To die or not to die: death signaling in nonalcoholic fatty liver disease
Yuko Akazawa et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
Sharda Anroedh et al.
JOURNAL OF LIPID RESEARCH (2018)
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
Natalia Wasilewska et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Role of SREBPs in Liver Diseases: A Mini-review
Azam Moslehi et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction
Leonardo P. de Carvalho et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease
Nynke Simons et al.
GASTROENTEROLOGY (2017)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Exome-wide association study of plasma lipids in >300,000 individuals
Dajiang J. Liu et al.
NATURE GENETICS (2017)
Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
Leonore Wigger et al.
CELL REPORTS (2017)
Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis
William L. Holland et al.
MOLECULAR METABOLISM (2017)
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics
Melania Manco
CHILDREN-BASEL (2017)
Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC MEDICINE (2017)
Sphingolipids in mitochondria
Maria Jose Hernandez-Corbacho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort
Aki S. Havulinna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Ceramide synthases in biomedical research
Francesca Cingolani et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
Panu K. Luukkonen et al.
JOURNAL OF HEPATOLOGY (2016)
Inverting the Topology of a Transmembrane Protein by Regulating the Translocation of the First Transmembrane Helix
Qiuyue Chen et al.
MOLECULAR CELL (2016)
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
Shunquan Wu et al.
SCIENTIFIC REPORTS (2016)
Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity
S. Rodriguez-Cuenca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis
Jonathan Y. Xia et al.
CELL METABOLISM (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Dihydroceramides: From Bit Players to Lead Actors
Monowarul Mobin Siddique et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
PNPLA3 I148M variant in nonalcoholic fatty liver disease: Demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis
Li-Zhen Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance
Sarah M. Turpin et al.
CELL METABOLISM (2014)
CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance
Suryaprakash Raichur et al.
CELL METABOLISM (2014)
Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency
Kirill Tarasov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
Krzysztof Kurek et al.
LIVER INTERNATIONAL (2014)
Sustained Induction of Collagen Synthesis by TGF-β Requires Regulated Intramembrane Proteolysis of CREB3L1
Qiuyue Chen et al.
PLOS ONE (2014)
Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes
Sarah Brice Russo et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
Bray Denard et al.
ELIFE (2012)
Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels
Kittichai Promrat et al.
HEPATOLOGY RESEARCH (2011)
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
William L. Holland et al.
NATURE MEDICINE (2011)
Adiponectin, a key adipokine in obesity related liver diseases
Christa Buechler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane
Vidyaramanan Ganesan et al.
APOPTOSIS (2010)
Adiponectin: A Key Player in Obesity Related Disorders
Yuji Matsuzawa
CURRENT PHARMACEUTICAL DESIGN (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
Ralf A. Claus et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis
Puneet Puri et al.
HEPATOLOGY (2009)
Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
Juichi Fukushima et al.
HEPATOLOGY RESEARCH (2009)
Involvement of Acid β-Glucosidase 1 in the Salvage Pathway of Ceramide Formation
Kazuyuki Kitatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE
Zheng Zheng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
Maud Lemoine et al.
LIVER INTERNATIONAL (2009)
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Naim Alkhouri et al.
Expert Review of Gastroenterology & Hepatology (2009)
Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
Steve S. Choi et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Catherine Postic et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Increase of ceramide in the liver and plasma after carbon tetrachloride intoxication in the rat
Ikuyo Ichi et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice
Hitoshi Matsumoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations
Leah J. Siskind et al.
MITOCHONDRION (2006)
A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome
SA Summers et al.
DIABETES (2005)
Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein
TS Worgall et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Enlargement and contracture of C2-ceramide channels
LJ Siskind et al.
BIOPHYSICAL JOURNAL (2003)
Modulation of transforming growth factor-β (TGF-β) signaling by endogenous sphingolipid mediators
M Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKC zeta-dependent mechanism
DJ Powell et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins
LJ Siskind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
De novo sphingolipid biosynthesis:: A necessary, but dangerous, pathway.
AH Merrill
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The lipids C2- and C16-ceramide form large stable channels -: Implications for apoptosis
LJ Siskind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
